ReviewFrontiers in medicine2023

Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: systematic review.

Abdullah A Alqarni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.